Thyrocare Technologies Ltd. Annual Reports

NSE: THYROCARE | BSE: 539871

Expensive Performer

902.30 55.65 (6.57%)

1.7M NSE+BSE Volume

NSE 25 Apr, 2025 3:31 PM (IST)

Margin Growth

Thyrocare Technologies' EBITDA margin expands 8.9% YoY to 30.8% in Q4FY25 See details